Category: Finance
-
Nanoparticle Therapy Start-Up Gains $4M in Early Funds
A start-up enterprise developing treatments for autoimmune disorders using protein-laden nanoparticles is raising $4 million in its first venture funding round.
-
$1.2M Challenge Seeking More Accurate Mammograms
A new challenge is seeking better computer models that interpret mammograms with fewer erroneous results, resulting in fewer unneeded medical tests.
-
Small Business Grant Funds Flu Therapy R&D
A biotechnology company in South Dakota is developing an influenza therapy, with backing from a National Institutes of Health program supporting research by small enterprises.
-
Takeda Awarded $19.8 Million for Zika Vaccine
Takeda Pharmaceutical Company is receiving $19.8 million from a U.S. public health agency for initial steps to develop a vaccine to prevent Zika infections.
-
Small Business Award Funding Epilepsy Drug Research
A federal grant is funding a project by Neuroene Therapeutics, a start-up enterprise in South Carolina to develop a new class of drugs to treat epilepsy.
-
Computer Models to Boost 3-D Print Designs in Mfring
An academic-industry team is developing computer-based methods to improve the design for three-dimensional printing of complex manufactured items.
-
NSF Funding Data Mining for Depression Diagnosis
A computer scientist at University of Texas in Arlington is developing data mining techniques and algorithms to help clinicians analyze unstructured notes accumulated from patients in therapy for depression.
-
Biopharm Company Raising $40 Million in IPO
Omeros Corporation, a biopharmaceutical company developing drugs that prevent inflammation in surgeries, is raising $40 million in its initial public stock offering.
-
NIH Funding Trial of Precise Tumor Removal System
A company making a system to guide surgery that promises more complete removal of breast tumors received funding for a large-scale clinical trial testing the technology.
-
FDA Funding Brain Tumor Treatment Trial
The biotechnology company DNAtrix is receiving a grant from U.S. Food and Drug Administration to support a clinical trial of its virus-delivered immunotherapy to treat an aggressive form of brain cancer.